Firefly Neuroscience Inc (AIFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 150 | 101 | 38 | -9 | N/A |
| Depreciation Amortization | 10 | 14 | 9 | 5 | N/A |
| Accounts receivable | -2,170 | -1,026 | -138 | -227 | N/A |
| Accounts payable and accrued liabilities | 963 | 709 | 27 | 20 | N/A |
| Other Working Capital | -900 | -192 | -48 | -117 | N/A |
| Other Operating Activity | 1,288 | 375 | 118 | 210 | 0 |
| Operating Cash Flow | $-660 | $-18 | $5 | $-118 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | -8 | -6 | N/A | N/A |
| Other Investing Activity | 0 | 5 | 3 | 0 | 0 |
| Investing Cash Flow | $-20 | $-3 | $-3 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 6 | 0 | 0 | 2 | 0 |
| Financing Cash Flow | $6 | $N/A | $N/A | $2 | $N/A |
| Beginning Cash Position | 1,960 | 1,968 | 1,968 | 1,968 | N/A |
| End Cash Position | 1,280 | 1,947 | 1,970 | 1,852 | N/A |
| Net Cash Flow | $-680 | $-21 | $2 | $-116 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -660 | -18 | 5 | -118 | N/A |
| Capital Expenditure | -24 | -8 | -6 | N/A | N/A |
| Free Cash Flow | -684 | -26 | -1 | -118 | 0 |